Structural model of haptoglobin and its complex with the anticoagulant ecotin variants: structure–activity relationship study and analysis of interactions

References

• Levy AP, Asleh R, Blum S, et al. Haptoglobin: basic and clinical aspects. Antioxidants Redox Signal 2010;12:293–304
   PubMed Web of Science ®Google Scholar
• Alayash AI. Haptoglobin: old protein with new functions. Clin Chim Acta 2011;412:493–8
   Google Scholar
• Nielsen MJ, Petersen SV, Jacobsen C, et al. A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem 2007;28:1072–9
   Google Scholar
• Andersen CBF, Torvund-Jensen M, Nielsen MJ, et al. Structure of the haptoglobin-HB complex. Nature 2012;489:456–9
   PubMed Web of Science ®Google Scholar
• Theilgaard-Mönch K, Jacobsen LC, Nielsen MJ, et al. Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood 2006;108:353–61
   Google Scholar
• Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 2004;345:35–42
   PubMed Web of Science ®Google Scholar
• Wassell J. Haptoglobin: function and polymorphism. Clin Labo 2000;46:547–52
   PubMedGoogle Scholar
• Wicher KB, Fries E. Evolutionary aspects of hemoglobin scavengers. Antioxidants Redox Signal 2010;12:249–59
   Web of Science ®Google Scholar
• Ye B, Cramer DW, Skates SJ, et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer. Clin Cancer Res 2003;9:2904–11
   PubMed Web of Science ®Google Scholar
• Zhang S, Shu H, Luo K, et al. N-linked glycan changes of serum haptoglobin beta chain in liver disease patients. Mol BioSyst 2011;7:1621–8
   PubMed Web of Science ®Google Scholar
• Boonyapranai K, Tsai HY, Chen MC, et al. Glycoproteomic analysis and molecular modeling of haptoglobin multimers. Electrophoresis 2011;32:1422–32
   Google Scholar
• Ettrich R, Brandt W, Baumruk V, et al. Study of chaperone-like activity of human haptoglobin: conformational changes under heat shock conditions and localization of interaction sites. Biol Chem 2002;383:1667–76
   Google Scholar
• Di Cera E. Serine proteases. IUBMB Life 2009;61:510–15
   PubMed Web of Science ®Google Scholar
• Guex N, Peitsch MC. SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714–23
   PubMed Web of Science ®Google Scholar
• Varfolomeev SD, Gariev IA, Uporov IV. Catalytic sites of hydrolases: structures and catalytic cycles. Russian Chem Rev 2005;74:61
   Google Scholar
• Polticelli F, Bocedi A, Minervini G, Ascenzi P. Human haptoglobin structure and function -- a molecular modelling study. FEBS J 2008;275:5648–56
   Google Scholar
• Yang SQ, Craik CS. Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator1. J Mol Biol 1998;279:1001–11
   Google Scholar
• Zani ML, Moreau T. Phage display as a powerful tool to engineer protease inhibitors. Biochimie 2010;92:1689–704
   Google Scholar
• Bachovchin DA, Cravatt BF. The pharmacological landscape and therapeutic potential of serine hydrolases. Nat Rev Drug Discov 2012;11:52–68
   PubMed Web of Science ®Google Scholar
• Castro HC, Monteiro RQ, Assafim M, et al. Ecotin modulates thrombin activity through exosite-2 interactions. Int J Biochem Cell Biol 2006;38:1893–900
   Google Scholar
• Krarup A, Wallis R, Presanis JS, et al. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One 2007;2:e623
   PubMedGoogle Scholar
• Dass K, Ahmad A, Azmi AS, et al. Evolving role of uPA/uPAR system in human cancers. Cancer Treatment Rev 2008;34:122–36
   PubMed Web of Science ®Google Scholar
• Parmar N, Albisetti M, Berry LR, Chan AKC. The fibrinolytic system in newborns and children. Clin Lab 2006;52:115–24
   PubMed Web of Science ®Google Scholar
• Watson CJ. Post-lactational mammary gland regression: molecular basis and implications for breast cancer. Expert Rev Mol Med 2006;8:1–15
   Google Scholar
• De Lima DC, Alvarez Abreu P, De Freitas CC, et al. Snake venom: any clue for antibiotics and cam? Evid Based Complement Alternat Med 2005;2:39–47
   Google Scholar
• McGrath ME, Gillmor SA, Fletterick RJ. Ecotin: lessons on survival in a protease-filled world. Protein Sci 1995;4:141–8
   PubMed Web of Science ®Google Scholar
• Sathler PC, Craik CS, Takeuchi T, et al. Engineering ecotin for identifying proteins with a trypsin fold. Appl Biochem Biotechnol 2010;160:2355–65
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 1970;227:680–5
   PubMed Web of Science ®Google Scholar
• McGrath ME, Hines WM, Sakanari JA, et al. The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli. J Biol Chem 1991;266:6620–5
   Google Scholar
• Maruyama M, Sugiki M, Yoshida E, et al. Broad substrate specificity of snake venom fibrinolytic enzymes: possible role in haemorrhage. Toxicon 1992;30:1387–97
   PubMedGoogle Scholar
• Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Molr Biol 1990;215:403–10
   PubMed Web of Science ®Google Scholar
• Abreu PA, Albuquerque MG, Rodrigues CR, Castro HC. Structure–function inferences based on molecular modeling, sequence-based methods and biological data analysis of snake venom lectins. Toxicon 2006;48:690–701
   Google Scholar
• Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006;22:195–201
   PubMed Web of Science ®Google Scholar
• Kiefer F, Arnold K, Künzli M, et al. The SWISS-MODEL repository and associated resources. Nucleic Acids Res 2009;37:D387–92
   PubMed Web of Science ®Google Scholar
• Budayova-Spano M, Lacroix M, Thielens NM, et al. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J 2002;21:231–9
   Google Scholar
• Budayova-Spano M, Grabarse W, Thielens NM, et al. Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. Structure 2002;10:1509–19
   Google Scholar
• Castro HC, Silva DM, Craik C, Zingali RB. Structural features of a snake venom thrombin-like enzyme: thrombin and trypsin on a single catalytic platform? Biochim Biophys Acta – Protein Struct Mol Enzymol 2001;1547:183–95
   PubMedGoogle Scholar
• Bernstein FC, Koetzle TF, Williams GJ., et al. The protein data bank: a computer-based archival file for macromolecular structures. J Mol Biol 1977;112:535–42
   PubMed Web of Science ®Google Scholar
• Gillmor SA, Takeuchi T, Yang SQ, et al. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases1. J Mol Biol 2000;299:993–1003
   PubMed Web of Science ®Google Scholar
• Katz BA, Sprengeler PA, Luong C, et al. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets. Chem Biol 2001;8:1107–21
   PubMedGoogle Scholar
• Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283–91
   Web of Science ®Google Scholar
• Schwarzenbacher R, Zeth K, Diederichs K, et al. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 1999;18:6228–39
   PubMed Web of Science ®Google Scholar
• Gaboriaud C, Rossi V, Bally I, et al. Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle. EMBO J 2000;19:1755–65
   Google Scholar
• Wejman JC, Hovsepian D, Wall JS, et al. Structure of haptoglobin and the haptoglobin-hemoglobin complex by electron microscopy. J Mol Biol 1984;174:319–41
   PubMed Web of Science ®Google Scholar
• Tanramluk D, Schreyer A, Pitt WR, Blundell TL. On the origins of enzyme inhibitor selectivity and promiscuity: a case study of protein kinase binding to staurosporine. Chem Biol Drug Des 2009;74:16–24
   PubMed Web of Science ®Google Scholar
• Varshney A, Sen P, Ahmad E, et al. Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality 2010;22:77–87
   PubMed Web of Science ®Google Scholar
• Laboissiere MC, Young MM, Pinho RG, et al. Computer-assisted mutagenesis of ecotin to engineer its secondary binding site for urokinase inhibition. J Biol Chem 2002;277:26623–31
   PubMed Web of Science ®Google Scholar
• Wang CI, Yang Q, Craik CS. Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin. J Biol Chem 1995;270:12250–6
   PubMed Web of Science ®Google Scholar